USD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$286.46M
Market Cap
-
P/E Ratio
-1.02
EPS
$6.28
52 Week High
$0.67
52 Week Low
HEALTHCARE
Sector
| Field | Value (CNY) |
|---|---|
| Gross Profit | $899M |
| Total Revenue | $1.5B |
| Cost Of Revenue | $568M |
| Costof Goods And Services Sold | $568M |
| Operating Income | -$624M |
| Selling General And Administrative | $324M |
| Research And Development | $165M |
| Operating Expenses | $1.5B |
| Investment Income Net | - |
| Net Interest Income | $47M |
| Interest Income | $47M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $46M |
| Income Before Tax | -$588M |
| Income Tax Expense | -$905K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$587M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$84M |
| Ebitda | -$38M |
| Net Income | -$590M |
| Field | Value (CNY) |
|---|---|
| Total Assets | $2.7B |
| Total Current Assets | $1.7B |
| Cash And Cash Equivalents At Carrying Value | $588M |
| Cash And Short Term Investments | $588M |
| Inventory | $152M |
| Current Net Receivables | $226M |
| Total Non Current Assets | $1B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $127M |
| Intangible Assets Excluding Goodwill | $127M |
| Goodwill | $684K |
| Investments | - |
| Long Term Investments | $280M |
| Short Term Investments | $599M |
| Other Current Assets | $160M |
| Other Non Current Assets | - |
| Total Liabilities | $776M |
| Total Current Liabilities | $630M |
| Current Accounts Payable | - |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $115M |
| Total Non Current Liabilities | $146M |
| Capital Lease Obligations | $170M |
| Long Term Debt | - |
| Current Long Term Debt | $70M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $240M |
| Other Current Liabilities | $516M |
| Other Non Current Liabilities | $1.3M |
| Total Shareholder Equity | $1.8B |
| Treasury Stock | - |
| Retained Earnings | -$886M |
| Common Stock | $290K |
| Common Stock Shares Outstanding | $134M |
| Field | Value (CNY) |
|---|---|
| Operating Cashflow | -$26M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $46M |
| Capital Expenditures | $63M |
| Change In Receivables | - |
| Change In Inventory | -$37M |
| Profit Loss | - |
| Cashflow From Investment | $257M |
| Cashflow From Financing | -$22M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $44M |
| Dividend Payout Common Stock | $44M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$18M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$587M |
| Field | Value (CNY) |
|---|---|
| Gross Profit | $899M |
| Total Revenue | $1.5B |
| Cost Of Revenue | $568M |
| Costof Goods And Services Sold | $568M |
| Operating Income | -$624M |
| Selling General And Administrative | $324M |
| Research And Development | $165M |
| Operating Expenses | $1.5B |
| Investment Income Net | - |
| Net Interest Income | $47M |
| Interest Income | $47M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $46M |
| Income Before Tax | -$588M |
| Income Tax Expense | -$905K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$587M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$84M |
| Ebitda | -$38M |
| Net Income | -$590M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-04-08 |
| Declaration Date | 2025-03-28 |
| Record Date | 2025-04-08 |
| Payment Date | 2025-04-25 |
| Amount | 0.0265 |
Sector: HEALTHCARE
Industry: HEALTH INFORMATION SERVICES
So-Young International Inc. (SY) is a premier online platform dedicated to the burgeoning field of consumer health and medical aesthetics, offering a comprehensive suite of discretionary medical treatments. Utilizing advanced technology to streamline interactions between consumers and service providers, the company enhances user engagement within the rapidly expanding aesthetic market. With a strategic focus on addressing the rising demand for aesthetic procedures, So-Young is committed to fostering a well-informed user base through educational resources while maintaining an unwavering emphasis on quality and customer satisfaction. As a key player in the health-tech sector, So-Young is poised for significant growth and further solidification of its leadership position in the medical aesthetics industry.